Pyridam Farma Tbk vs Kian Santang Muliatama Tbk. — how do they compare? Pyridam Farma Tbk trades at Rp214 (market cap 2.31T, 10.47M 24h volume), while Kian Santang Muliatama Tbk. trades at Rp214 (market cap 315.19B, 8.5M 24h volume). The key difference: Pyridam Farma Tbk is far larger — about 7.3× Kian Santang Muliatama Tbk.'s market cap, and Pyridam Farma Tbk is more actively traded (10.47M versus 8.5M). Which is the better fit depends on your goals.
| PYFA | RGAS | |
|---|---|---|
Market Cap | 2.31T | 315.19B |
Volume | 10.47M | 8.5M |
Lot | 104.73K | 84.96K |
Turnover | 2.2B | 1.82B |
Average Price | 209.71 | 214.14 |
Value | 2.2B | 1.82B |
Indicative Equilibrium Price | 214 | 214 |
Indicative Equilibrium Volume | 10.89K | 893 |
Trailing returns across standard periods
Latest headlines on both assets
PT. Pyridam Farma Tbk. Founded in Jakarta based on Limited Company Act on November 27th 1976 and start the commercial operation since 1978 which conduct in pharmaceutical business.On its first establishmnent, the corporate produce & distribute medicine products for livestock & pet.. Since 1985 the corporate develop pharmacy division which emphasize produce and distribute health product for human and for livestock held by veterinary division.
Read more on PYFA →PT Kian Santang Muliatama Tbk (the Entity) was established based on the Notarial Deed of Artisa Khamelia Ramadiyanti, S.H., M.Kn., No. 634, dated November 28, 2018. The Entity started its commercial operations on 2019. The controlling party for the Company is Edy Nurhamid Amin.
Read more on RGAS →